Compare CCCC & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCCC | ALTO |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.1M | 194.1M |
| IPO Year | 2020 | 2005 |
| Metric | CCCC | ALTO |
|---|---|---|
| Price | $2.75 | $4.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $12.20 | N/A |
| AVG Volume (30 Days) | ★ 2.7M | 2.3M |
| Earning Date | 05-25-2026 | 06-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $35,947,000.00 | ★ $965,258,000.00 |
| Revenue This Year | N/A | $10.58 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 1.02 | N/A |
| 52 Week Low | $1.09 | $0.76 |
| 52 Week High | $3.82 | $4.65 |
| Indicator | CCCC | ALTO |
|---|---|---|
| Relative Strength Index (RSI) | 53.55 | 82.27 |
| Support Level | $2.14 | $0.95 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.34 | 0.28 |
| MACD | 0.02 | 0.25 |
| Stochastic Oscillator | 38.82 | 94.32 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under four segments: Marketing and distribution, Pekin Campus production, Western production, and Corporate.